Estefany Rios-Guzman, Lacy M Simons, Taylor J Dean, Francesca Agnes, Anna Pawlowski, Arghavan Alisoltanidehkordi, Hannah H Nam, Michael G Ison, Egon A Ozer, Ramon Lorenzo-Redondo, Judd F Hultquist
Respiratory Syncytial Virus (RSV) is a leading cause of acute respiratory tract infection, with the greatest impact on infants, immunocompromised individuals, and older adults. RSV prevalence decreased substantially in the United States (US) following the implementation of COVID-19-related non-pharmaceutical interventions but later rebounded with abnormal seasonality. The biological and epidemiological factors underlying this altered behavior remain poorly defined. In this retrospective cohort study from 2009 to 2023 in Chicago, Illinois, US, we examined RSV epidemiology, clinical severity, and genetic diversity...
April 20, 2024: Nature Communications